Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease
Open Access
- 25 March 2021
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-12
Abstract
Prion diseases are distinguished by long pre-clinical incubation periods during which prions actively propagate in the brain and cause neurodegeneration. In the pre-clinical stage, we hypothesize that upon prion infection, transcriptional changes occur that can lead to early neurodegeneration. A longitudinal analysis of miRNAs in pre-clinical and clinical forms of murine prion disease demonstrated dynamic expression changes during disease progression in the affected thalamus region and serum. Serum samples at each timepoint were collected whereby extracellular vesicles (EVs) were isolated and used to identify blood-based biomarkers reflective of pathology in the brain. Differentially expressed EV miRNAs were validated in human clinical samples from patients with human sporadic Creutzfeldt-Jakob disease (sCJD), with the molecular subtype at codon 129 either methionine-methionine (MM, n = 14) or valine-valine (VV, n = 12) compared to controls (n = 20). EV miRNA biomarkers associated with prion infection predicted sCJD with an AUC of 0.800 (85% sensitivity and 66.7% specificity) in a second independent validation cohort (n = 26) of sCJD and control patients with MM or VV subtype. This study discovered clinically relevant miRNAs that benefit diagnostic development to detect prion-related diseases and therapeutic development to inhibit prion infectivity.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (1132604)
This publication has 56 references indexed in Scilit:
- Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sitesNature Communications, 2011
- The prion protein as a receptor for amyloid-βNature, 2010
- miRNA malfunction causes spinal motor neuron diseaseProceedings of the National Academy of Sciences, 2010
- MicroRNAs and deregulated gene expression networks in neurodegenerationBrain Research, 2010
- Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob diseaseBrain, 2009
- Argonaute HITS-CLIP decodes microRNA–mRNA interaction mapsNature, 2009
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1Journal of Biological Chemistry, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor proteinProceedings of the National Academy of Sciences, 2007